Marijuana Approach Bias Retraining and Neural Response in Youth

Completed · Not applicable · Has a placebo group

Conditions studied: Alcohol Approach/Avoidance Task, Sham Approach/Avoidance Task

In brief

This study aims to determine if a marijuana (MJ) Approach Avoidance Task (AAT) intervention reduces cannabis use compared to a control condition containing no active components of AAT. Adolescent heavy MJ users (N=40, ages 16-21) will be randomly assigned to MJ-AAT (n=20) or control condition (MJ-Sham, n=20) for three weeks. The MJ-AAT includes six sessions designed to reduce action tendencies to approach marijuana. The MJ-Sham includes six MJ-AAT-sham conditions. Substance use and cognitive assessment will identify changes in MJ use patterns and mechanisms of treatment outcomes. Additionally, using an functional magnetic resonance imaging marijuana cue reactivity task, we will determine differences in neural response in reward regions before and after 3 weeks of either AAT or sham treatment.

Key facts

Study ID

NCT02723149

Run by

Medical University of South Carolina

People needed

41

Starts

2015-11-01

Expected to finish

2017-10-01

Last updated by the study team

2018-09-28

Who can join

Age: 16 and older, up to 21. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• between age 16 and 21
• having >50 lifetime marijuana use episodes and a pattern of at least weekly marijuana use for the past year (>1+/week for 52 weeks) at study entry.

You may not qualify if…

• not having a parent to consent (for those under age 18)
• prenatal alcohol (>2 drinks on an occasion or >4 drinks in a week) or any tobacco or illicit drug exposure
• premature birth (<34 weeks gestation), birth weight <5 lbs, or other gestational or perinatal complications
• history of a serious medical or neurological problems that could affect blood oxygen level dependent (BOLD) response, brain development, or study participation, including diabetes and recurrent migraine
• current severe Diagnostic and Statistical Manual of Mental Disorders (DSM-5) major Axis I psychiatric disorder (i.e., exclude participants with bipolar disorder, psychotic disorder)
• use of any illicit substance (e.g., cocaine, methamphetamines) other than alcohol or marijuana > 100 times
• history of major neurological disorder or head trauma (with loss of consciousness >10 minutes)
• history of learning disability, pervasive developmental disorder, or other condition requiring special education
• current use of medications that affect cerebral blood flow
• non-correctable visual or hearing problems
• non-fluent in English
• MRI contraindications (e.g., braces, claustrophobia, irremovable metal implants or piercings)
• pregnant on day of scan
• intake of psychoactive medication as tested by urine drug screen.

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.